Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

University of Lyon, Pulsalys grant iDD biotech key patent and IP rights for mAb development

Executive Summary

Pulsalys, the tech transfer office of the University of Lyon, granted iDD biotech SAS exclusive global rights to antibodies and patents targeting CK8 (cytokeratin 8), which iDD will use to scale up and enhance development of iDD005, its preclinical candidate against CK8.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies